Phase 1RecruitingINTERVENTIONAL
Effect of Insulin Lowering on Lipogenesis
ClinicalTrials.gov · NCT07403604 · Registry updated: 2026-07-06
- Condition / research focus
- Hyperinsulinemia; Insulin Resistance; Non-Alcoholic Fatty Liver Disease; Prediabetic State; Obesity
- Sponsor
- Columbia University
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2026-07-01. Completion: 2029-09-30 (may be estimated). No results posted in this registry response.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Placebo (drug) — also listed as: Placebo solution
- Diazoxide Oral Suspension, 2 mg per kg per dose (drug) — also listed as: Proglycem
- Deuterated water (2H2O/D2O), 70% (drug) — also listed as: Heavy water
- Insulin Suppression Test (IST) (diagnostic_test)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.